It’s an appealing income play to consider Compass Therapeutics Inc. (CMPX)

After finishing at $3.81 in the prior trading day, Compass Therapeutics Inc. (NASDAQ: CMPX) closed at $4.21, up 10.50%. In other words, the price has increased by $+0.4000 from its previous closing price. On the day, 728733 shares were traded. CMPX stock price reached its highest trading level at $4.6050 during the session, while it also had its lowest trading level at $3.9700.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

Our goal is to gain a better understanding of CMPX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.80 and its Current Ratio is at 12.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On March 15, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.

On January 19, 2022, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $10.B. Riley Securities initiated its Buy rating on January 19, 2022, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 24 when Schuetz Thomas J. bought 20,000 shares for $4.19 per share. The transaction valued at 83,800 led to the insider holds 5,451,873 shares of the business.

Bisker-Leib Vered sold 2 shares of CMPX for $9 on Nov 25. The Chief Operating Officer now owns 1,060,414 shares after completing the transaction at $4.36 per share. On Nov 23, another insider, Bisker-Leib Vered, who serves as the Chief Operating Officer of the company, sold 9,569 shares for $4.30 each. As a result, the insider received 41,147 and left with 1,060,416 shares of the company.

Stock Price History:

Over the past 52 weeks, CMPX has reached a high of $5.65, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is 4.6514, while the 200-Day Moving Average is calculated to be 3.1257.

Shares Statistics:

The stock has traded on average 227.60K shares per day over the past 3-months and 427.81k shares per day over the last 10 days, according to various share statistics. A total of 126.19M shares are outstanding, with a floating share count of 101.41M. Insiders hold about 5.10% of the company’s shares, while institutions hold 50.60% stake in the company. Shares short for CMPX as of Oct 13, 2022 were 167.76k with a Short Ratio of 0.93M, compared to 52.09k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.17% and a Short% of Float of 0.23%.

Earnings Estimates

Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.16, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.13.

Analysts are recommending an EPS of between -$0.33 and -$0.44 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is -$0.47, with 6 analysts recommending between -$0.36 and -$0.68.